Observations placeholder
Pepcid and Famotidine
Identifier
005558
Type of Spiritual Experience
Background
A description of the experience
Famotidine
Famotidine is commonly marketed under the trade names Pepcidine and Pepcid and under the trade name Gaster. It was first marketed in 1981. It is a histamine H2-receptor antagonist that inhibits stomach acid production, and it is commonly used in the treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD/GORD).. "Unlike cimetidine, the first H2 antagonist, famotidine has no effect on the cytochrome P450 enzyme system, and does not appear to interact with other drugs". They say
Pepcid RPD orally-disintegrating tablets (that are not swallowed) were released in 1999. Generic preparations became available in 2001, e.g. Fluxid or Quamatel. In the United States, a product called Pepcid Complete is available that combines famotidine with an antacid in a chewable tablet to ameliorate the relatively slow onset of effects. In the UK, this product is known as Pepcidtwo. Certain preparations of famotidine are available over the counter (OTC) in various countries.
On Mar, 20, 2015: 22,367 people reported to have side effects when taking Pepcid. Among them, 135 people (0.60%) have Hallucination.
Time on Pepcid when people have Hallucination :
| < 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
| Hallucination | 75.00% | 12.50% | 0.00% | 0.00% | 0.00% | 0.00% | 12.50% |
Gender of people who have Hallucination when taking Pepcid :
| Female | Male | |
| Hallucination | 65.00% | 35.00% |
Age of people who have Hallucination when taking Pepcid :
| 0-1 | 2-9 | 10-19 | 20-29 | 30-39 | 40-49 | 50-59 | 60+ | |
| Hallucination | 0.00% | 0.00% | 2.54% | 0.00% | 5.08% | 7.63% | 11.02% | 73.73% |